Search

Your search keyword '"Brennan MS"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Brennan MS" Remove constraint Author: "Brennan MS"
36 results on '"Brennan MS"'

Search Results

1. Comparison of Postoperative Outcomes of Patients Undergoing Total Hip and Total Knee Arthroplasty Following a Diagnosis of Dementia: A TriNetX Database Study

2. Racial Disparities in Outcomes of Total Joint Arthroplasty at a Single Institution: Have We Made Progress?

3. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice

4. A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax

5. Analysis of Risk Factors for High-Risk Patients Undergoing Total Joint Arthroplasty

7. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis

8. MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia

10. Whose Home Is This Anyway? Resident Rights Education

11. The Role of Physical Therapy in Multidisciplinary Stroke Rehabilitation

12. Characterisation of a novel A1-specific monoclonal antibody

13. Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells.

14. A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.

15. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.

17. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.

18. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.

19. MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia.

20. TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.

21. Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use.

22. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.

23. DNA repair processes are critical mediators of p53-dependent tumor suppression.

24. Frailty Assessments in Surgical Practice: What is Frailty and How Can It Be Used in Prosthetic Health?

25. Using a Complex Patient Management Scenario to Help Bridge the Education-Practice Gap.

26. Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

27. Mosquito Control Practices and Zika Knowledge Among Outdoor Construction Workers in Miami-Dade County, Florida.

28. The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes.

29. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.

30. The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

31. Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms.

32. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.

33. Characterization of Phytophthora spp. Isolated from Ornamental Plants in Florida.

34. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro.

35. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo.

36. Characterisation of a novel A1-specific monoclonal antibody.

Catalog

Books, media, physical & digital resources